Home

Formerly HCRI, the Baim Institute for Clinical Research is a leading, non-profit academic research organization (ARO) that delivers insight, innovation and leadership in today’s dynamic research environment. We collaborate with the world’s most highly respected researchers from renowned institutions to help advance health and quality of life around the world.

450+

Studies managed since 1993

50+

FDA Submissions

250+

Publications

160K+

Enrolled Subjects

Services

Featured Studies

Defining the Clinical Pathway for the Emerging Valve Space

Designing and executing a pivotal clinical trial for a small emerging device company



Health Economics and Quality of Life

Many sponsors seeking for approval for innovative, first-in-class medical devices have found that Economic and Quality of Life (EQoL) studies can be a valuable asset in the overall commercialization process

The DAPT Study: A Case Study in Collaboration

The Dual Antiplatelet Therapy Study (DAPT) was a landmark clinical trial which we designed and managed, with the objective of determining the appropriate duration of dual antiplatelet therapy following placement of a drug-eluting coronary stent.

VIEW ALL STUDIES

Latest from Baim

Baim Institute Names Dr. C. Michael Gibson As CEO

  • Event

12.05.17

Pioneering Cardiologist Is Also Entrepreneur And Educator

Mordecai Kramer, MBA Chairing ICI17 Panel

  • Event

12.01.17

Baim Institute’s Executive Director of Business Development, Mordecai Kramer, MBA, will be chairing an 8:30 AM panel at ICI Meeting 2017 in Tel Aviv, Israel. The panel title is “Technology Parade I Devices” and is bound to be an interesting discussion. Please see the link below for more information.

Dr. Laura Mauri Interview with Circulation

  • Event

11.28.17

Dr. Laura Mauri and colleagues, Circulation’s Editors, Discuss Late Breaking Science. Start at minute 11 for Dr. Mauri’s discussion.

VIEW ALL LATEST FROM BAIM